Avantor(NYSE) AVTR

Avantor, Inc. helps scientists and doctors do their work. They make high-purity chemicals and specialized lab tools. These products help companies create new medicines and tech.

What Does Avantor Do?

• VWR Distribution & Services: Supplies laboratory consumables, which are items used up during research, and provides technical services; generated $1,240.5 million in net sales in the three months ended June 30, 2026.
• Bioscience & Medtech Products: Manufactures process chemicals and silicone materials used for medical device and drug production; recorded $451.8 million in net sales in the three months ended June 30, 2026.

Reorganizing for the Future

• Implemented a new internal reporting structure on Jan. 1, 2026, to better manage its two core segments.
• Authorized a $500.0 million share repurchase program in Oct. 2025 to return capital to stockholders.
• Concluded a multiyear cost transformation initiative in 2025 to improve company-wide efficiency and productivity.
• Sold the Clinical Services business in 2024 to refine its focus on core biopharmaceutical and medical technology markets.

Specialized Support for Science

Avantor operates a global distribution and manufacturing network across the Americas, Europe, and Asia. It specializes in custom-formulated materials and high-purity chemicals essential for making drugs from biological sources.

A Look at Recent Performance

• Net sales were $1,692.3 million in the three months ended June 30, 2026, up 0.5% year over year.
• Organic net sales (a non-GAAP figure that removes the effects of currency changes and acquisitions) fell 0.4% in the three months ended June 30, 2026.
• Net income was $38.1 million in the three months ended June 30, 2026, compared to $64.7 million in the prior-year period.
• Adjusted EBITDA (a non-GAAP metric representing profit before interest, taxes, and non-cash costs) reached $254.3 million in the three months ended June 30, 2026, down 9.1% year over year.
• Total liquidity reached $1,686.6 million as of June 30, 2026, including cash and available credit.

Bottom Line

Avantor has evolved from a broad distributor into a specialized partner for the life sciences and healthcare sectors. The company recently reorganized its business segments to focus resources on its most productive biopharmaceutical and medical technology operations.